Related posts
Markets mixed as first vaccines reach North AmericaBiotech can be a big win or a big loss. A lot of companies have binary outcomes, their product either works or it doesn’t. This company recently had a significant disappointment. US investors are not very sympathetic to these types of situations. They shoot first and ask questions later. If you want to own biotech, he would suggest you own a tech with lots of different products, or buy an ETF that gives you a basket. This one is a broken stock.
(Top Short Mar 9/07. Up 202%.) News on this was positive so he exited his short position.
(Top Short March 9/07.) You would have entered at about $37 and with your trailing stop you would have been out in a few days and probably would've broken even including your commissions. Had expected bad news, but they had some positive news.
Alexion Pharmaceuticals is a American stock, trading under the symbol ALXN-Q on the NASDAQ (ALXN). It is usually referred to as NASDAQ:ALXN or ALXN-Q
In the last year, there was no coverage of Alexion Pharmaceuticals published on Stockchase.
Alexion Pharmaceuticals was recommended as a Top Pick by on . Read the latest stock experts ratings for Alexion Pharmaceuticals.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Alexion Pharmaceuticals published on Stockchase.
On 2021-07-20, Alexion Pharmaceuticals (ALXN-Q) stock closed at a price of $183.08.